Summary

KEY HIGHLIGHTS

•    Antiviral Drug Development and Treatment Strategies,  including   Vaccination
•    Influenza Control Strategies
•    Clinical Trials & Drug Development
•    AI Vaccine Development – Capacity & Capability
•    Virulence And Pathogenecity
•    Country Updates – Egypt, Vietnam, Indonesia, Pakistan & India

And Much More!

 

For more information visit: http://www.avianinfluenzasummit.com/

Summary

Following the huge success of the previous five events, this conference will focus on how to make brand different, effective, and above all, most profitable!

REQUEST your FREE CONFRENCE BROCHURE to really appreciate the outstanding, high caliber speaker panel, main topics of discussion and detailed program packed with real-life and high value case studies.
Come along to Barcelona and listen to Gian Piero Reverberi, Senior VP International Specialty Pharma, who will be representing the “PharmaTimes” award winner European Marketing Company of the Year, Shire Pharmaceuticals. 
Malcolm Allison from Actelion Switzerland will address the issue of achieving internal communication in branding with aligning strategy all throughout the organization.
Niki Morabbi from AstraZeneca UK will describe how global branding works in local setting and how differences between the USA and the rest of the world markets could be managed.  On the other hand, Bozidar Jovicevic from Novartis Greece will highlight the importance of storytelling in pharmaceutical marketing in order support the brand building process, both externally and internally. …more information…
For detailed information simply REPLY or REQUEST your free conference brochure to appreciate the real value of this MUST ATTEND event!

Should you have any questions or require any further assistance please contact Silvia Anderson on +421 257 272 120 or email silvia.anderson@jacobfleming.com

For more information visit: http://www.jacobfleming.com/conferences/life-science/6th-annual-pharma-branding

Summary

The annual TechConnect Summit represents one of the worlds largest peer-vetted deal flow for technology Partnering, Investing and Licensing. The 2008 TechConnect Summit will take place June 3-5 at the Hynes Convention Center, Boston, MA, USA.The TechConnect Summit features pre-screened IPs, early stage company presentations, corporate needs talks, networking opportunities, and exclusive access to the global business technology community, including business and investment professionals, leading university researcher directors, and government organizations.

For more information visit: http://www.techconnect.org/Summit2008/

Summary

The sales team is the driving force behind a pharmaceutical company. New trends and strategies have been emerging in the industry so organizations need to stay ahead of the competition when approaching and selling to clients. It is necessary for your sales team to gain better physician access, find new routes of communication, and understand the different approaches needed for primary and specialized care and to stay educated by re-vamping your training and development programs.

This conference brings together senior level executives from the top pharmaceutical companies leading the way with innovative sales force techniques. Through interactive sessions, case studies, and discussion panels, participants will gain insight on how to build a stronger and more effective sales force. In this highly interactive environment, delegates will have the opportunity to network, benchmark, and share strategies on how their company is driving growth to new levels through sales force effectiveness.

For more information visit: http://www.jacobfleming.com/conferences/life-science/pharma-sales-force-effectiveness-1

Summary

Successful generics companies understand, that effective business development & licensing are essential to sustain major market leadership. The whole area of licensing, partnering and co-development is growing and this surge is predicted to continue.

Give your licensing strategy the best chance of success! Join us at this event and together with the experts from the generics industry benchmark their direct experiences with high level licensing deals and analyse the impact of regulatory environment on generics, including the authorities’ perspective.

For more information visit: http://www.jacobfleming.com/conferences/life-science/3rd_annual_licensing_in_generics?part

Summary

With millions of future euros, dollars, pounds and yen at stake, and the constant threat of litigation, it is absolutely critical that patent counsel and executives for pharmaceutical, biotech and chemical companies and their advisors, have the tools and knowledge they need to make a sound and competent freedom to operate determination.

Just how do you correctly determine if you truly have freedom to operate in a given area of research?

Building on the success of our previous events in London and Munich, C5 is proud to present the 5th International Freedom to Operate forum. This event will bring together an outstanding faculty of leading in-house counsel and expert attorneys to share important information on the latest developments in your industry.

For more information visit: http://www.c5-online.com/pharma_biotech/fto.htm?PageMode=Search

Summary

The TriMark Cancer Biomarker 2008 Conference has been organized to provide a critical examination of the latest in cancer diagnosis, as well as to provide insight from key industry leaders concerning cutting-edge technology platforms. This conference will also provide a forum for leaders in cancer biomarkers to share ideas, network with other delegates and advance understanding of the potential of new cancer detection technologies. The agenda will include:

Who Should Attend:

•    Cancer diagnostics company representatives.
•    In vitro diagnostic companies management and R&D directors.
•    Biotechnology companies.
•    Medical devices manufacturers.
•    Diagnostic laboratory directors and staff.


Leaders from the Following Areas Will Greatly Benefit from Attending:

•    Clinical Laboratory leaders.
•    Hospital CFOs and CSOs.
•    Physicians.
•    Cancer diagnostics developers.
•    Business development leaders.
•    Strategic planning and development personnel.
•    Technology development.
•    Marketing.
•    Research and development.


Key Themes:

•    A critical examination of key emerging biomarker technologies for cancer diagnostics.
•    Formation of successful alliances.
•    Application of emerging technologies to cancer diagnostics.
•    Transitioning from laboratory in vitro diagnostics to clinical management of cancer patients.
•    The emerging role of cancer diagnostic tests in personalized medicine.
•    The intersection of genomics and cancer diagnostics with personalized medicine.


Questions Answered in the TriMark Conference:

•    What will the cancer diagnostics market be worth by the end of the decade?
•    Which market key segments will drive cancer diagnostics market growth?
•    Which new technologies will reach the cancer diagnostics market in the next 2-3 years?
•    How is technology innovation impacting the dynamics and direction of the diagnostics industry?
•    How can clinical labs bring new cancer diagnostic tests to patent care?
•    What are the key challenges in gaining acceptance of new technologies by users, payers and regulators?
•    How is technology innovation facilitating the transition of new cancer diagnostics testing into standard healthcare practice?


Top Five Reasons to Attend the TriMark Conference:

•    Discover the cancer biomarkers sectors with the greatest prospective growth, ensuring you can successfully align your future strategies with predicted success.
•    Evaluate the competitive dynamics of the cancer biomarkers market and understand the changing relationship between IVD companies and the cancer diagnostics testing sector.
•    Identify the key players in the cancer biomarkers market, recognize lucrative partnering opportunities and benchmark your strategies against the leading players.
•    Assess opportunities and challenges faced by diagnostic companies in gaining acceptance of innovative technologies by payers, regulators and users.
•    Understand the factors driving growth of the cancer biomarkers market.


Registration Fees for the Conference:

•    Early-Bird Registration Fee is $295 until April 30, 2008. 
•    Standard Registration Fee is $395 on and after May 1, 2008. 
•    At-the-Door Fee $500 on June 16, 2008 (subject to seating availability). 

Register at http://www.trimarkpublications.com/conferences/


About TriMark Publications, LLC

Based in New York City, TriMark Publications is a global leader in biotechnology, healthcare and life sciences publishing. For more information, please visit http://www.trimarkpublications.com/conferences/.

For more information visit: http://www.trimarkpublications.com/conferences/

Summary

What value does your HR add to your organization? Are you utilizing the best approaches to recruit top talent? Are your strategies sustainable? Do you know what practices your industry peers are using? 

Regardless of the size of your organization, in a highly competitive market like Pharmaceuticals and Biotechnology, people are the key to driving sustainability and promoting growth. This event brings together top HR experts from leading Pharma and Biotech companies of all sizes. They will showcase their experiences and approaches to find the best and most effective employees.
 
You will get an insight of where the HR function is heading, developing leaders, the role of management in overall success, and how to make your strategies work long term.

For more information visit: http://www.jacobfleming.com/buxus/generate_page.php?page_id=1616

Summary

As a result of society’s fascination with looking youthful and beautiful, the global cosmeceuticals market is one of the fastest growing segments of personal care segment valued at $55 billion.

Anti-aging products are set to maintain the leading category within the skin care market estimated to account for 60% percent of the overall cosmeceutical product demands in 2010. Natural and organic beauty brands have also become high in demand as consumers search for a more natural solution to looking beautiful inside and out.  These emerging beauty trends are fueling new opportunities for product innovations.

For more information visit: http://www.almevents.com/cosmeceuticals

Summary

It is estimated that pharma patent expirations equalling 140 billion USD in losses will occur over the next 10 years. Upon generic entry into the market place branded pharma risk losing more than 80% of their market share.

Escalating pipeline burdens and the latest legal developments are radically changing the landscape for pharma patent lifecycles in Europe and the US. As a private practice lawyer or in-house counsel, you need to be alert to all the latest legislative and case law developments affecting lifecycle management in order to stay ahead of the game.

With the patent endgame stakes being higher than ever before for the pharma industry, this event is not to be missed.

For more information visit: http://www.c5-online.com/ppl.htm

Summary

The IXth World Conference on Clinical Pharmacology and Therapeutics (CPT 2008) is fast approaching; it will be held in Québec City, Canada from July 27th to August 1st, 2008. CPT 2008 is organized by the Canadian Society for Clinical Pharmacology and the National Research Council of Canada under the auspices of the International Union of Basic and Clinical Pharmacology.

Abstracts can be submitted online at http://www.cpt2008.org/e_call/call_e.shtml until February 1st, 2008. Notice of acceptance will be sent by March 31st, 2008. Accepted abstracts will be presented at poster sessions that will take place each day with viewing times during lunch and coffee breaks.

A stellar program has been put together by Dr. Patrick du Souich and his Scientific Program Committee. There will be two Plenary Sessions per day presented by distinguished and experienced speakers. The 39 oral symposia will feature outstanding speakers from around the world. Topics will include: New Insights in Treatment of Pain, Drug Transport and Metabolism in the Brain, Towards Quality Use of Medicines, Traditional Chinese Medicine, Pharmacogenetic Epidemiology, Pharmacovigilance, Geriatric Pharmacology, Prevention of Left Ventricular Hypertrophy and Cardiac Remodelling, Pediatric Pharmacology, and more. In addition, there will be a series of industry-sponsored symposia each day from 18:00 to 20:00. An exhibition, including displays by commercial and non-profit organizations, with companies showcasing innovative products and services, will be an integral part of the meeting.

CPT08 includes the 5th Canadian Therapeutics Congress (Canadian Society for Clinical Pharmacology, Canadian Association for Population Therapeutics, Canadian College of Clinical Pharmacy). A number of satellite symposia will be held in Québec City or in nearby centres just before or right after CPT 2008.

CPT 2008 will also include exciting social activities. Participants will not want to miss the Opening Ceremony featuring Inuit throat-singing, Huronne-Wendat dancing, and a unique show of forces (!) between French and English. Another event not to be missed is Fun Night on Thursday, August 31st; it will be a colourful evening combining food, refreshments and a circus performance in the tradition of Cirque du Soleil.

Québec City will be celebrating its 400th anniversary in 2008 with a series of events offering a daring touch of imagination and charm. Participants at CPT 2008 will also want to explore the province of Québec, known for its Joie de Vivre, or to visit other destinations in Canada.

The meeting website is active and it is already possible to make hotel reservations: see http://www.cpt2008.org/e_accomo/accommodation_e.shtml. It is recommended that participants book early because the 400th anniversary of Québec City is expected to attract many tourists.

The Early Registration Deadline is April 30 2008. Registrants before that date will benefit from a reduced registration fee. It is already possible to register on-line at http://www.cpt2008.org/e_regist/registration_e.shtml. A limited number of partial travel grants will be offered to young scientists from low and middle income countries.

To learn more about CPT 2008, please visit the Conference website at www.cpt2008.org or contact the Conference Secretariat at cpt2008@nrc-cnrc.gc.ca

We look forward to welcoming you at CPT 2008 in Québec City next summer!

For more information visit: http://www.cpt2008.org/e_mainmenu/welcome_e.shtml

Summary

* The Pharma CI Conference is widely attended by a large variety of executives from large, medium-sized, and  smaller pharmaceutical and biotechnology companies. This conference is the industry standard for professionals  in the pharma CI community. 

 * You will be provided with real insights, deep discussions, fresh     ideas and validating your corporate strategies in energizing  forums. 
    
 * You will gain knowledge and understand how industry changes are effecting and will continue to effect the way  you look at and position your brand, your next launch, your detailing, your pipeline, your sales force, your  own position within your company and the impact it has on your competition. 

For more information visit: http://www.pharmaciconference.com

Summary

The 2^nd annual World Drug Safety Congress brings together top pharmaceutical, biotechnology and regulatory representatives in a forum that addresses the key issues of the industry. The in-depth programme covers the detection, analysis and prevention of adverse drug reactions with case studies and industry experiences as well as global regulatory coverage of developments in the US, Japan, Europe, Asia/Pacific, South America and Canada.

The meeting is set to bridge the gap between international regulatory bodies, industry professionals and academic representatives and address how to drive pharmacovigilance operations forward into the 21^st Century.

For more information visit: http://www.terrapinn.com/2008/safety

Summary

Following on from the huge success of the Exploratory Clinical Development World Europe

the congress will give you a critical insight into the latest strategies on how the industry is addressing and elevating the current challenges in early clinical development.

Exploratory Clinical Development World Americas you will gain the opportunity to hear about some of the scientific techniques being used to modernise drug development and to address the bottlenecks in early clinical development including computer models and simulation to predict device failures, qualified biomarkers, and innovative study designs.

For more information visit: http://www.healthnetworkcommunications.com